Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Astria Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 33 | 30 | −3 |
| Shares | 6.21M | 5.73M | −477.9K (−7.7%) |
| Value | $41.7M | $17.2M | −$24.5M (−58.7%) |
New holders (4)
Institutions that held Astria Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boothbay Fund Management, LLC | 75,773 | $227.0K | 0.01% |
| Millennium Management LLC | 16,917 | $51.0K | 0.00% |
| Renaissance Technologies LLC | 13,700 | $41.0K | 0.00% |
| UBS Group AG | 25 | $0 | 0.00% |
Sold out (7)
Institutions that held Astria Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| VR Adviser, LLC | 538,999 | $3.62M |
| D. E. Shaw & Co., Inc. | 24,809 | $166.0K |
| Susquehanna International Group, LLP | 18,530 | $124.0K |
| Occudo Quantitative Strategies LP | 15,341 | $103.0K |
| Corton Capital Inc. | 11,597 | $78.0K |
| Schonfeld Strategic Advisors LLC | 11,500 | $77.0K |
| Royal Bank of Canada | 145 | $1.00K |